Here’s an interesting take on The Croods: A New Age (often searched as “IMDb Croods 2”)—focusing on its unlikely journey from development hell to a surprisingly sharp sequel. If you type “IMDb Croods 2” into a search bar today, you’ll see a tidy score: 7.0/10 . A solid “pretty good.” But that number hides one of the most chaotic, improbable, and oddly fascinating production stories in modern animation.
The film’s smartest move is refusing to make the Bettermans villains. They’re just… annoying. And lonely. And their obsession with “better” has left them joyless. By the end, the two families merge their flaws—a surprisingly mature lesson for a movie with a character named “Thunk.” Here’s the strangest piece of Croods 2 trivia: the animators reused unused dream sequences from the cancelled 2016 version for the “nightmare fuel” scenes. That means some of the film’s weirdest, most psychedelic moments—Grug fighting a giant popcorn monster, Eep turning into a wolf—were literally salvaged from a dead movie. They’re ghosts of a sequel that never was, haunting the one that survived. So Why Does “IMDb Croods 2” Still Get Searched? Because the film became a quiet pandemic comfort watch. Families stuck at home needed something loud, colorful, and reassuring. The Croods: A New Age delivered: a story about two very different tribes learning that “better” doesn’t mean “different”—it means together. Even if together involves a lot of screaming, falling, and one very large cat with anger issues. imdb croods 2
Why? Because the sequel took a weird, self-aware swing. The plot—the Croods meeting the superior, farm-owning Bettermans—is essentially a . There’s a “thunder sister” side plot, a punch-puppy named Chunky, and a sequence where characters literally get high on “nightmares.” It’s unhinged in a way the first film wasn’t. The Secret Weapon: The “Bettermans” Dynamic Where The Croods was about family vs. nature, A New Age is about toxic self-improvement . Phil Betterman (voiced by Peter Dinklage) is a smug, gluten-free, wall-having prehistoric yuppie. He represents everything Grug fears: change, inadequacy, and the idea that being a “good father” means building a fortress, not jumping off cliffs together. Here’s an interesting take on The Croods: A
Let’s rewind. The Croods (2013) was a surprise hit—$587 million worldwide, a heartfelt caveman-family road trip, and a rare DreamWorks success after a few misfires. A sequel was announced immediately. Then… nothing. For seven years . By 2016, The Croods 2 was officially dead. DreamWorks had been acquired by Universal, and the new regime pulled the plug. Animators moved on. Scripts were buried. Fans mourned a movie that would never be. The film’s smartest move is refusing to make
The Croods 2 shouldn’t work. That it does—and with such weird, wild heart—is its own kind of prehistoric miracle.
Except—in 2017, a miracle happened. (voice of Grug) revealed in an interview that the sequel was “back on.” How? A combination of Netflix sniffing around for original animated content and Universal realizing the first film was a streaming goldmine. The movie was resurrected like a prehistoric phoenix, given a fraction of the normal production time, and somehow… released in November 2020. What Makes the IMDb Score Interesting A 7.0 isn’t groundbreaking, but context matters. The Croods 2 landed during peak COVID, in theaters and on PVOD, a risky hybrid release. Critics were lukewarm (75% on Rotten Tomatoes), but audiences loved it. The IMDb user reviews tell a clear story: “Better than the first” appears constantly.
Genelux Corporation is committed to developing safe and effective next-generation immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our goal is to ensure access to our investigational therapies at the appropriate time and in a clinically appropriate manner for patients.
Outside of our clinical trials, we may provide physician-requested expanded access to its investigational products under limited situations. This is initiated when the primary purpose is to diagnose, prevent, or treat a serious condition in a patient, which is different from a clinical trial where more comprehensive safety and efficacy data are collected. At Genelux, we recognize and understand the need for an early/expanded access policy for patients who have serious or immediately life-threatening disease and have limited available treatment options.
The request for access to a Genelux investigational drug will be considered only if the patient is an eligible patient, meaning:
In addition, prior to setting up an expanded access program or granting a request from an eligible patient’s physician, Genelux will consider whether:
At this time, based on these factors, Genelux believes that participation in one of our clinical trials is the only appropriate way to access our investigational therapies.
If the investigational drug is approved by a regulatory agency for commercial use, including provisional approval, existing expanded access programs will be phased out or modified accordingly.
Patients interested in seeking an expanded access to a Genelux investigative drug should talk to their physician. All requests must be made by the patient’s treating physician by email at . We will, in general, acknowledge receipt of a request for expanded access within five business days. We may ask for more detailed information to fully evaluate a request.
The request for access to an investigative drug can only be considered if the requesting physician agrees to obtain applicable regulatory and ethics committee approvals. We may deny access if the treating physician cannot guarantee an appropriate storage and handling of the investigative drug, which typically requires a temperature controlled deep freezer and follows Biosafety Level 2 safety procedures and precautions. The treating physician must agree to comply with regulatory obligations, including safety monitoring and reporting.
For more information on expanded access from the FDA, click here.